204 related articles for article (PubMed ID: 31543415)
1. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study.
Asada H
Vaccine; 2019 Oct; 37(44):6776-6781. PubMed ID: 31543415
[TBL] [Abstract][Full Text] [Related]
2. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
[TBL] [Abstract][Full Text] [Related]
3. VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia.
Imoto K; Okazaki A; Onishi F; Miyazaki Y; Okeda M; Yano S; Takao Y; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Iso H; Yamanishi K; Asada H;
J Dermatol Sci; 2015 Sep; 79(3):235-40. PubMed ID: 26070505
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in cell-mediated immunity after varicella-zoster virus skin test in the general population; Shozu Herpes Zoster Study: SHEZ study.
Ikeda D; Imano H; Mori Y; Asada H; Yamanishi K; Okuno Y; Iso H
J Med Virol; 2023 Jan; 95(1):e28336. PubMed ID: 36418204
[TBL] [Abstract][Full Text] [Related]
7. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
Weinberg A; Zhang JH; Oxman MN; Johnson GR; Hayward AR; Caulfield MJ; Irwin MR; Clair J; Smith JG; Stanley H; Marchese RD; Harbecke R; Williams HM; Chan IS; Arbeit RD; Gershon AA; Schödel F; Morrison VA; Kauffman CA; Straus SE; Schmader KE; Davis LE; Levin MJ;
J Infect Dis; 2009 Oct; 200(7):1068-77. PubMed ID: 19712037
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic features of recurrent herpes zoster (HZ).
Nakamura Y; Miyagawa F; Okazaki A; Okuno Y; Mori Y; Iso H; Yamanishi K; Asada H;
J Am Acad Dermatol; 2016 Nov; 75(5):950-956.e1. PubMed ID: 27473453
[TBL] [Abstract][Full Text] [Related]
9. Immunization to reduce the frequency and severity of herpes zoster and its complications.
Oxman MN
Neurology; 1995 Dec; 45(12 Suppl 8):S41-6. PubMed ID: 8545018
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
[TBL] [Abstract][Full Text] [Related]
11. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster.
Park SY; Kim JY; Kwon JS; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2019 Nov; 91(11):1995-2000. PubMed ID: 31286531
[TBL] [Abstract][Full Text] [Related]
12. A community-based survey of varicella-zoster virus-specific immune responses in the elderly.
Tang H; Moriishi E; Okamoto S; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
J Clin Virol; 2012 Sep; 55(1):46-50. PubMed ID: 22771002
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
[TBL] [Abstract][Full Text] [Related]
14. Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.
Okuno Y; Takao Y; Miyazaki Y; Ohnishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Mori Y; Asada H; Iso H; Yamanishi K;
Epidemiol Infect; 2013 Apr; 141(4):706-13. PubMed ID: 23218021
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of Varicella-Zoster Virus Infection.
Laing KJ; Ouwendijk WJD; Koelle DM; Verjans GMGM
J Infect Dis; 2018 Sep; 218(suppl_2):S68-S74. PubMed ID: 30247598
[TBL] [Abstract][Full Text] [Related]
16. Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
Krasselt M; Baerwald C; Liebert UG; Seifert O
Clin Rheumatol; 2019 Sep; 38(9):2493-2500. PubMed ID: 31028550
[TBL] [Abstract][Full Text] [Related]
17. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.
Irwin MR; Levin MJ; Laudenslager ML; Olmstead R; Lucko A; Lang N; Carrillo C; Stanley HA; Caulfield MJ; Weinberg A; Chan IS; Clair J; Smith JG; Marchese RD; Williams HM; Beck DJ; McCook PT; Zhang JH; Johnson G; Oxman MN
Clin Infect Dis; 2013 Apr; 56(8):1085-93. PubMed ID: 23413415
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.
Tyring SK; Stek JE; Smith JG; Xu J; Pagnoni M; Chan IS; Silber JL; Parrino J; Levin MJ
Clin Vaccine Immunol; 2012 Sep; 19(9):1411-5. PubMed ID: 22787198
[TBL] [Abstract][Full Text] [Related]
20. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
Sadaoka K; Okamoto S; Gomi Y; Tanimoto T; Ishikawa T; Yoshikawa T; Asano Y; Yamanishi K; Mori Y
J Infect Dis; 2008 Nov; 198(9):1327-33. PubMed ID: 18774884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
